Antibody Localization
Antibody Localization - Related Videos
04:13
A Technique to Assess the In Vivo Localization of Tumor-Specific Antibodies
0 Views •
2025
This video demonstrates a technique to study the in vivo localization of tumor-specific antibodies in a mouse tumor xenograft model. Upon subcutaneously injecting cancer cells into mice for tumor formation, fluorescently-labeled antibodies are injected that bind to tumor-specific receptors, enabling in vivo assessment of antibody localization via imaging.
07:51
Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling
0 Views •
2026
This protocol describes single-antibody labeling (SAL) to resolve the nanoscale spatial organization of plasma membrane proteins. By leveraging cumulative antibody-epitope interactions at the single-molecule level, membrane SAL (mSAL) maps local epitope distributions while simultaneously capturing antibody binding behavior in the native cellular environment.
03:10
In Vivo Fluorescence Imaging to Localize Antibodies in a Mouse Tumor Xenograft Model
0 Views •
2025
The video demonstrates a fluorescence imaging method for in vivo antibody localization in a mouse tumor xenograft model. It involves the injection of tumor cells in a mouse to generate solid xenografts beneath the skin. Subsequent injection of fluorescent antibodies confirms specific localization through enhanced fluorescence signals within the tumor xenograft.
06:15
An In Vivo Immunofluorescence Localization Method to Study Antibody Biodistribution
0 Views •
2025
This video demonstrates an in vivo immunofluorescence localization (IVIL) technique to study the biodistribution of tumor-targeting antibodies in a murine model of breast cancer. Upon the intravenous injection of a tumor-specific antibody in the mouse, the tumor is surgically isolated, and the localization of the antibody within the tumor tissue is confirmed via ex vivo immunostaining.
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
FAQs
The primary antibody binds a specific epitope, meaning a defined molecular region on its target antigen. Wherever that epitope occurs, antibody binding creates a detectable location within the specimen. The resulting pattern therefore reflects the distribution of the recognized antigen rather than the overall presence of antibodies, allowing researchers to associate particular pathogen or host components with specific cellular or tissue regions.
A labeled primary antibody can bind the target epitope directly, while a labeled secondary antibody can detect a primary antibody that has already bound its target. In both arrangements, the antibody-antigen interaction determines where the signal appears, and the labeling strategy determines how those binding sites become visible through fluorescence or enzymatic color development.
The location of an antigen relative to the cell provides information about its distribution during infection. Antibody localization can show whether a pathogen component or other target lies inside cells or outside them, adding spatial context that simple detection cannot provide. This distinction helps researchers examine infection biology and relate antigen position to observed immune responses.
Researchers apply a primary antibody that recognizes the target epitope, either use its label directly or add a labeled secondary antibody, and then examine the specimen with an appropriate imaging method. Immunofluorescence reveals binding sites through fluorescence, whereas immunohistochemistry uses enzymatic color development. The observed signal is interpreted according to its position in cells or tissue.
The choice depends on how the antibody-binding sites should be visualized. Immunofluorescence provides a fluorescent readout, while immunohistochemistry produces enzymatic color development. Both methods can reveal where a target is distributed, so researchers can select the approach that fits the imaging and specimen context of an immunology or infection study.
This approach can identify pathogen components in infected specimens, map antigens across tissue sections, and show the distribution of immune-cell or antigen targets. Those spatial observations support investigations of infection biology and host responses. They can also contribute to diagnostic studies and experiments focused on how immune mechanisms operate within cells, tissues, or infected samples.